WATANABE, H., TAMURA, T., SHIOZAWA, T., OHARA, G., KAGOHASHI, K., KAWAGUCHI, M., . . . HIZAWA, N. (2015). Response to alectinib after one year of discontinuation of crizotinib in anaplastic lymphoma kinase-positive non-small-cell lung cancer: A case report. Mol Clin Oncol.
Chicago-stil citatWATANABE, HIROKO, TOMOHIRO TAMURA, TOSHIHIRO SHIOZAWA, GEN OHARA, KATSUNORI KAGOHASHI, MIO KAWAGUCHI, KOICHI KURISHIMA, HIROAKI SATOH, och NOBUYUKI HIZAWA. "Response to Alectinib After One Year of Discontinuation of Crizotinib in Anaplastic Lymphoma Kinase-positive Non-small-cell Lung Cancer: A Case Report." Mol Clin Oncol 2015.
MLA-referensWATANABE, HIROKO, et al. "Response to Alectinib After One Year of Discontinuation of Crizotinib in Anaplastic Lymphoma Kinase-positive Non-small-cell Lung Cancer: A Case Report." Mol Clin Oncol 2015.